Recent Posts
- EXINI Diagnostics AB, a Lantheus company (EXINI), announced today a ‘License and Development’ agreement with Curium, a world leader in nuclear medicine , to customize EXINI’s artificial intelligence (AI) platform for use in Europe.
- EXINI Executes Agreement with Siemens Healthineers for the Distribution of its PSMA Artificial Intelligence Technology aPROMISE and quantitative assessment technology of bone scans aBSI
- EXINI Executes Agreement with Bayer AG for the Distribution of its PSMA Artificial Intelligence Technology aPROMISE and quantitative assessment technology of bone scans aBSI
- EXINI Diagnostics AB (EXINI) collaboration with the Prostate Cancer Clinical Trials Consortium (PCCTC)
- EXINI’s Artificial Intelligence enabled product received FDA clearance on GE Healthcare’s XELERIS platform
Recent Comments
No comments to show.